The potential of carnosine supplementation to reduce cardiometabolic risk:a double-blind, placebo-controlled trial.

  • de Courten, Barbora (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusFinished
Effective start/end date1/01/16 → 31/12/16

Funding

  • Royal Australasian College of Physicians (RACP): A$50,000.00